B cell therapy with the anti-CD22 monoclonal antibody epratuzumab

Comment on the editorial by St.Clair and Tedder

  • Tedder, Thomas F. PhD
  • St. Clair, E. William MD

  • Duke University Medical Center, Durham, NC

Arthritis & Rheumatism 54(7):p 2344-2345, July 2006.
Copyright © 2006, American College of Rheumatology